report by BlackRock
Results for ""
Market Outlooks
Weekly Market Compass: Brian Levitt and Talley Léger continue their discussion about what could impact a 2021 economic recovery
This piece is approved to use with clients.
The “recovery” trade is a hot topic of conversation, and so far the trends appear to support that storyline. But it’s important to watch out for blind spots and biases. Recently, we sat down to discuss what we’re seeing in the markets and the questions that could surprise us in 2021.
Market Outlooks
Weekly Market Compass: I Address nine issues to follow over the next few weeks
This piece is approved to use with clients.
This is the last blog of the year for me. And what a year it has been — one full of loss. Loss of people, first and foremost, and also of businesses. It was just reported the other day that New York icon The 21 Club will be closing for good, the latest of many service-related businesses to sadly fall victim to the pandemic. I think we are all eagerly waiting to close the books on 2020 and looking forward to brighter days in 2021.
Investing Ideas
Investing in Diversity: Analyzing the Investment Risks and Opportunities
This piece is approved to use with clients.
Olivia Gull, Analyst on the Governance and Responsible Investment Team, discusses the importance of diversity and inclusion from an investment perspective, and key indicators that investors can look out for when analyzing a company’s diverse culture.
Investing Ideas
Technology Fuels Long-Term Growth Prospects for Manufacturing
This piece is approved to use with clients.
Assistant Portfolio Manager David Chung discusses the ongoing recovery in the manufacturing sector and how technological innovation is helping drive longer-term growth in certain industries.
Investing Ideas
Whitepaper: The Case for Active Management within Agency MBS
Investors should consider an allocation to agency MBS because, as an asset class with little to no credit risk, it has historically delivered strong absolute and risk-adjusted returns, with low correlation to equities. MBS have demonstrated their defensive capabilities across a variety of market conditions, making it an attractive asset class in today’s environment. MBS’ favorable liquidity profile combined with its inherent complexity creates alpha opportunities, making it an attractive candidate to potentially add both alpha and diversity in sources of return to an investor’s portfolio.
Market Outlooks
Weekly Market Compass: Western economies may get worse before they get better
This piece is approved to use with clients.
While I have never lived in Florida, I have spent enough time there since childhood to be familiar with a weather phenomenon referred to as “the mean season.” It describes a brutal weather pattern that typically occurs in the late summer months.
Investing Ideas
Securitized Market Overview
This piece is approved to use with clients.
Securitizations are financial instruments created via the bundling of contractual debts, such as mortgages, or other assets that generate receivables, such as franchise fees. These bundles are then sold to investors, who collect the income from the underlying obligations.
Investing Ideas
Whitepaper: The Case for CLOs
This piece is approved to use with clients.
Key Takeaways
- CLOs offer portfolios of floating-rate bank loans securitized across the rating spectrum. The availability of floating-rate bonds is limited in the U.S., and the choices for high quality floating-rate securities is even more limited, yet around 80% of CLOs carry a credit rating from A to AAA.
- Relative to the investment-grade corporate credit market, CLOs have offered a consistent yield premium across the rating spectrum, in some cases as much as two times the yield offered over U.S. Treasuries.
- In an environment where interest rates are low and the risk of higher Treasury yields has risen, allocations to AAA rated CLOs may help investors diversify a traditional fixed income portfolio, offering lower volatility, higher credit-quality and less sensitivity to any rise in interest rates.
Investing Ideas
A Potential Turning Point in the Battle Against COVID-19
This piece is approved to use with clients.
Delivering better-than-expected trial data, a vaccine candidate from Pfizer and BioNTech could mark the beginning of the end of the pandemic and boost confidence in an economic recovery, now underway.